Your browser doesn't support javascript.
loading
Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage.
Mirabito Colafella, Katrina M; van Dorst, Daan C H; Neuman, Rugina I; Doorn, Leni van; Neves, Karla Bianca; Montezano, Augusto C; Garrelds, Ingrid M; van Veghel, Richard; de Vries, René; Uijl, Estrellita; Clahsen-van Groningen, Marian C; Baelde, Hans J; van den Meiracker, Anton H; Touyz, Rhian M; Visser, Willy; Danser, A H Jan; Versmissen, Jorie.
Afiliação
  • Mirabito Colafella KM; Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Physiology, Monash University, Melbourne, Australia.
  • van Dorst DCH; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Neuman RI; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Doorn LV; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Neves KB; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Montezano AC; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Garrelds IM; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.
  • van Veghel R; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.
  • de Vries R; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Uijl E; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Clahsen-van Groningen MC; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Baelde HJ; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • van den Meiracker AH; Department of Pathology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands.
  • Touyz RM; Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Visser W; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
  • Danser AHJ; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom.
  • Versmissen J; Division of Pharmacology and Vascular Medicine, Department of Internal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.
Clin Sci (Lond) ; 136(9): 675-694, 2022 05 13.
Article em En | MEDLINE | ID: mdl-35441670
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Hipertensão Limite: Animals / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Hipertensão Limite: Animals / Female / Humans / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article